Speak the Same Language in PsA

Speak the Same Language in PsA

Help improve the dialogue between psoriatic arthritis patients and their rheumatologists to enable effective disease diagnosis and treatment
Winners Announced

Challenge Overview

Problem Statement

The healthcare community is looking for new ways to improve diagnosis and treatment of Psoriatic Arthritis (PsA), an inflammatory auto-immune disease (the result of an overactive immune system). Subjective symptoms such as joint pain, stiffness, and tenderness can often lead to frustration and missed opportunities for better care. In fact, one study found that mis-alignment between patients and physicians on treatment satisfaction is associated with increased disease activity and worse impact on quality of life.[1] It’s important for patients with PsA to treat their condition early, because if left untreated, it can lead to permanent and irreversible joint damage.

This challenge is looking for a simple and easy to adopt solution to help:

  1. Patients communicate the full history of their symptoms and impact on their quality of life during doctor visits in the most relevant way;
  2. Physicians measure the severity and progression of their patients’ psoriatic arthritis symptoms and the impact on their quality of life; and
  3. Prompt a conversation between physicians and patients about how to take appropriate steps to improve disease outcomes

The solution should easily enable the physician to better understand the patient’s end-to-end experience, regardless of how much the patient recalls or measures their daily impact and how much time the physician has with them to evaluate the patient’s status. 

Ultimately, the solution will improve measurement of irregular and variable physical and emotional symptoms so both PsA patients and healthcare providers can evaluate the degree of severity and impact on quality of life. This more accurate understanding of patients’ symptoms will ease the development of treatment plans that match the severity and bothersomeness of patients’ symptoms.


[1] Furst DE et al. Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control. Clin Rheumatol. 2017;36(9):2045-2054.

Updates 13
Forum 8
Community 146
Additional Context
Community Guidelines

Community Guidelines

If you report an adverse event or product issue, we may collect and use your identifying information, such as your HeroX ID, email, name, location, health-related information, information shared on your HeroX profile, and other similar information in accordance with the law. This information is required to be submitted to the Novartis Drug Safety department and/or regulatory authorities. In such cases, we are also required to store your personal data for five years for auditing purposes. Please note that we may use third-party service providers to help us manage your comments and messages, which means that they too may have access to any personal information you share with us. We take steps to ensure that our service providers provide for adequate protection and security of your personal information.


Please note that HeroX also has access to information you share with us. For more details read the HeroX Privacy Policy.